Epstein-Barr Virus Infections Recruiting Phase 3 Trials for Lenalidomide (DB00480)

Also known as: Epstein-Barr Virus Infection / EBV Infections / EBV Infection / Epstein-Barr viral infections

IndicationStatusPhase
DBCOND0029759 (Epstein-Barr Virus Infections)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04084626PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBVTreatment